IR情報

2019/09/17~2020/02/17

IR情報&株価推移

日付始値高値安値終値前日比出来高時価総額25日乖離
2020
02/172,9632,9632,9072,918-2.24%38,3001511億8503万-4.48%
02/142,9512,9912,9502,985+0.64%52,9001546億5638万-2.55%
02/132,9602,9742,9112,966-0.74%39,0001536億7197万-3.29%
02/123,0403,0402,9652,988-2.03%60,0001548億1182万-2.77%
02/103,0803,0953,0503,050-2.09%47,4001580億2411万-0.81%
02/073,0953,1153,0703,115+1.14%33,9001613億9184万+1.2%
02/063,0803,1053,0753,080+0.82%77,5001595億7844万0%
02/053,0653,1003,0453,055+0.99%102,3001582億8317万-0.91%
02/042,9863,0502,9863,025+1.58%106,6001567億2883万-1.98%
02/0310:00 2型糖尿病治療薬「マリゼブ」の販売移管に関するお知らせ
02/032,9853,0302,9472,978-4.7%146,3001542億9370万-3.66%
01/3115:00 2020年3月期第3四半期決算短信〔日本基準〕(連結)
01/3115:00 2020年3月期第3四半期決算補足資料
01/313,0853,1603,0853,125+1.3%66,2001619億995万+0.9%
01/303,0853,1253,0803,085+0.16%59,4001598億3750万-0.39%
01/293,0603,0903,0503,080+1.15%57,2001595億7844万-0.61%
01/283,0303,0653,0103,045-0.16%64,6001577億6505万-1.81%
01/273,0303,0753,0253,050-0.97%45,0001580億2411万-1.8%
01/243,1053,1103,0553,080-0.96%39,2001595億7844万-0.87%
01/233,1403,1403,0953,110-0.64%39,1001611億3278万+0.1%
01/223,0953,1503,0953,130+1.79%48,1001621億6900万+0.81%
01/213,0703,1003,0703,075-0.65%21,8001593億1939万-0.87%
01/203,0553,1053,0503,095+1.81%32,3001603億5561万-0.19%
01/173,0653,0703,0303,040-0.33%32,7001575億600万-2%
01/163,0803,0903,0503,050-0.16%36,8001580億2411万-1.64%
01/153,0953,0953,0303,055-0.65%38,9001582億8317万-1.42%
01/143,1403,1453,0653,075-1.76%55,2001593億1939万-0.74%
01/103,1003,1453,1003,130+0.48%38,9001621億6900万+1.13%
01/093,1253,1653,0853,115+1.3%37,3001613億9184万+0.74%
01/083,0503,1003,0253,075-1.13%70,1001593億1939万-0.42%
01/073,0703,1203,0653,110+2.3%46,7001611億3278万+0.84%
01/063,0503,0653,0303,040-2.56%57,5001575億600万-1.3%
2019
12/303,1553,1553,1003,120-2.04%43,4001616億5089万+1.46%
12/273,1653,2103,1653,185+0.95%45,8001650億1862万+3.85%
12/263,1153,1553,1153,155+0.8%37,5001634億6428万+3.27%
12/253,1553,1553,1303,130-0.48%36,3001621億6900万+2.83%
12/243,1303,1603,1203,145+0.96%31,5001629億4617万+3.66%
12/233,1503,1553,1153,115-0.95%48,1001613億9184万+3.08%
12/203,1153,1553,0753,145+0.48%130,5001629億4617万+4.35%
12/193,1203,1553,1003,130+0.32%35,2001621億6900万+4.26%
12/183,1603,1603,0903,120-1.89%64,2001616億5089万+4.35%
12/173,1303,1953,1153,180+3.25%64,6001647億5956万+6.71%
12/163,0853,1153,0753,080+0.33%62,4001595億7844万+3.7%
12/133,1003,1103,0703,070+0.66%115,1001590億6033万+3.58%
12/123,0853,0953,0503,050-0.81%57,1001580億2411万+3.11%
12/113,0603,1303,0603,075+1.49%72,9001593億1939万+4.2%
12/103,0553,1053,0203,030-3.04%118,5001569億8789万+3.1%
12/0917:00 GnRHアンタゴニスト「リンザゴリクス(KLH-2109)」の海外における子宮筋腫を対象とした第3相臨床試験(PRIMROSE2試験)の中間解析結果について
12/093,0303,1403,0103,125+3.82%92,6001619億995万+6.62%
12/063,0053,0202,9713,010+0.17%51,9001559億5166万+3.19%
12/053,0403,0453,0003,005-0.66%36,8001556億9261万+3.3%
12/042,9693,0402,9693,025+0.5%64,8001567億2883万+4.27%
12/033,0353,0352,9823,010-1.31%38,6001559億5166万+4.08%
12/023,0253,0753,0253,050+1.33%61,2001580億2411万+5.76%
11/293,0153,0302,9973,010+0.94%71,3001559億5166万+4.73%
11/283,0203,0202,9442,982-0.93%93,7001545億95万+4.12%
11/273,0053,0752,9893,010+3.19%103,0001559億5166万+5.43%
11/2616:00 補体C5a受容体阻害剤「アバコパン(CCX168)」の国際共同第3相臨床試験(ADVOCATE試験)の結果について
11/262,9502,9672,9152,917-0.1%72,1001511億3322万+2.6%
11/252,9082,9232,8882,920+1.25%26,0001512億8866万+3.03%
11/222,8892,9122,8842,884+0.21%34,0001494億2345万+2.02%
11/212,9032,9152,8352,878-0.28%42,5001491億1259万+1.98%
11/202,8692,8902,8412,886+1.3%39,9001495億2707万+2.49%
11/192,8732,8872,8362,849-1.66%38,1001476億1006万+1.5%
11/182,8612,8972,8482,897+1.68%43,6001500億9700万+3.46%
11/152,8482,8722,8342,849+0.53%46,8001476億1006万+2.11%
11/142,8902,8902,8242,834-1.77%37,5001468億3289万+1.87%
11/132,9372,9572,8832,885-1.43%68,3001494億7526万+4.04%
11/122,9522,9522,9082,927-0.17%46,7001516億5133万+6.01%
11/112,9372,9662,9112,932+1%71,5001519億1039万+6.73%
11/082,9032,9272,8802,903+1.15%87,1001504億787万+6.07%
11/072,7352,8782,7352,870+2.65%124,4001486億9810万+5.28%
11/0615:00 2020年3月期第2四半期決算補足資料
11/0615:00 2020年3月期第2四半期決算短信〔日本基準〕(連結)
11/062,8242,8312,7732,796-1.1%63,0001448億6407万+2.98%
11/052,7952,8372,7652,827+2.24%108,6001464億7021万+4.43%
11/012,7912,7912,7472,765-1.5%53,3001432億5792万+2.41%
10/312,8122,8262,7912,807-0.07%70,2001454億3399万+4.16%
10/302,8092,8102,7772,8090%95,0001455億3761万+4.54%
10/292,8272,8362,8062,809+0.18%44,7001455億3761万+4.89%
10/282,8262,8282,7892,804+0.07%51,2001452億7856万+5.06%
10/252,7812,8072,7722,802+1.48%76,9001451億7494万+5.34%
10/242,7992,7992,7532,761+0.11%49,2001430億5068万+4.11%
10/232,7222,7632,6902,758+2.38%61,1001428億9524万+4.23%
10/212,7212,7282,6872,694-0.7%21,9001395億7933万+2.08%
10/182,7282,7622,7062,713-0.55%46,1001405億6374万+2.96%
10/172,7772,7772,7222,728-1.02%68,5001413億4091万+3.84%
10/162,7822,8002,7502,756+0.88%63,6001427億9162万+5.31%
10/152,7242,7822,6812,732+2.4%96,6001415億4815万+4.88%
10/112,6882,7002,6602,668-0.22%54,5001382億3224万+2.93%
10/102,6482,6832,6312,674+0.72%80,1001385億4310万+3.64%
10/092,6342,6632,6302,655+0.08%63,5001375億5869万+3.39%
10/082,6092,6552,6042,653+1.96%61,5001374億5507万+3.75%
10/072,6282,6372,5822,602+0.62%74,3001348億1270万+2.12%
10/042,5702,5942,5512,586+0.23%81,7001339億8372万+1.85%
10/032,5962,5962,5572,580-3.33%117,1001336億7285万+1.98%
10/022,6182,6812,6162,669+1.52%117,3001382億8405万+5.83%
10/012,6002,6412,6002,629+1.08%77,0001362億1160万+4.78%
09/302,5452,6092,5262,601+0.23%186,4001347億6089万+4%
09/272,6172,6252,5532,595-2.3%68,6001344億5002万+4.05%
09/262,6742,6922,6422,656+1.18%95,5001376億1050万+6.71%
09/252,6042,6372,5962,625+0.77%68,2001360億436万+5.68%
09/242,5862,6382,5822,605+0.81%73,6001349億6813万+5.08%
09/202,6122,6182,5842,584-0.88%90,2001338億8010万+4.49%
09/192,5772,6292,5702,607+1.44%68,9001350億7175万+5.67%
09/182,6032,6032,5472,570-1.12%52,1001331億5474万+4.34%
09/172,6012,6202,5692,599-0.5%73,5001346億5726万+5.65%